Makela Jan 4
4 · GE HealthCare Technologies Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Makela Jan
CEO, Imaging
Transactions
- Tax Payment
Common Stock, par value $0.01 per share
2024-03-01$91.28/sh−3,489$318,476→ 71,130 total - Tax Payment
Common Stock, par value $0.01 per share
2024-03-01$91.28/sh−3,424$312,543→ 67,706 total - Tax Payment
Common Stock, par value $0.01 per share
2024-03-01$91.28/sh−4,292$391,774→ 63,414 total - Tax Payment
Common Stock, par value $0.01 per share
2024-03-01$91.28/sh−8,154$744,297→ 55,260 total - Award
Common Stock, par value $0.01 per share
2024-03-01+8,088→ 63,348 total - Award
Employee Stock Option (right to buy)
2024-03-01+23,006→ 23,006 totalExercise: $92.72Exp: 2034-03-01→ Common Stock, par value $0.01 per share (23,006 underlying)
Footnotes (5)
- [F1]Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023.
- [F3]Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
- [F4]Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
- [F5]Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.